ORAMED PHARMACEUTICALS INC. Annual Return On Equity in % from 2021 to 2023

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Oramed Pharmaceuticals Inc. quarterly/annual Return On Equity history and growth rate from 2021 to 2023.
  • Oramed Pharmaceuticals Inc. Return On Equity for the quarter ending September 30, 2024 was 2.7 %.
  • Oramed Pharmaceuticals Inc. annual Return On Equity for 2023 was 3.61 %.
  • Oramed Pharmaceuticals Inc. annual Return On Equity for 2022 was -23.6 %, a 18.4% increase from 2021.
Return On Equity, Annual (%)
Return On Equity, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 3.61 +27.2 Jan 1, 2023 Dec 31, 2023
2022 -23.6 +5.32 +18.4% Jan 1, 2022 Dec 31, 2022
2021 -28.9 Sep 1, 2020 Aug 31, 2021
* An asterisk sign (*) next to the value indicates that the value is likely invalid.